Benadryl Allergy Tablet, Film Coated
NDC Package 70264-024-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Benadryl Allergy (diphenhydramine hydrochloride) tablets is take every 4 to 6 hours, or as directed by a doctordo not take more than 6 times in 24 hoursadults and children 12 years and over1 to 2 tabletschildren 6 to under 12 years1 tabletchildren under 6 yearsdo not use. This formulation utilizes a tablet, film coated delivery system. Marketed by R J General Corporation, this product is identified by NDC 70264-024 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
70264-024-01
Package Description
30 POUCH in 1 CARTON / 2 TABLET, FILM COATED in 1 POUCH
Product Code
70264-024
11-Digit Billing Format
70264002401
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Benadryl Allergy
Non-Proprietary Name
Diphenhydramine Hydrochloride
Substance Name
Diphenhydramine Hydrochloride
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1
Pharmacologic Class
Usage Information
Take every 4 to 6 hours, or as directed by a doctordo not take more than 6 times in 24 hoursadults and children 12 years and over1 to 2 tabletschildren 6 to under 12 years1 tabletchildren under 6 yearsdo not use

Regulatory & Marketing

Labeler Name
R J General Corporation
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70264-024-01 identifies a specific commercial package of 30 pouch in 1 carton / 2 tablet, film coated in 1 pouch of Benadryl Allergy, a human over the counter drug labeled by R J General Corporation. This tablet, film coated is formulated for oral use and contains diphenhydramine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by R J General Corporation on March 01, 2022. The current certification is valid through December 31, 2026.

How is this R J General Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70264002401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70264-024-01
11-Digit CMS (5-4-2)
70264-0024-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.